Advertisement Optigenex, Itochu Launch AC-11-melon In Japan - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Optigenex, Itochu Launch AC-11-melon In Japan

Optigenex has introduced AC-11-melon, a new oral capsule formulated by its partner, Itochu Corporation. The capsule utilizes patented AC-11 in combination with GliSODin, a cantaloupe melon extract rich in the vegetable antioxidant enzyme (SOD).

Itochu acts in partnership with Optigenex under a long-term exclusive supply and trademark licensing agreement, to market AC-11 bulk material and consumer products containing AC-11 under sublicenses in Japan and several other Asian countries. To date, the company has introduced AC-11 successfully to over 110 companies in the cosmetic and dietary supplement market, with 130 plus products containing AC-11 currently being marketed and sold in Japan.

AC-11 is the patented, all-natural rain forest botanical extract produced by Optigenex that helps the body’s natural ability to repair damage to DNA due to multiple causes, including harmful effects of UV radiation, stress, environmental pollution and other stressors. In its standard bulk powder form, AC-11 supplement may be consumed orally or combined with liposomes and other delivery mechanisms for topical application to the skin.

Daniel Zwiren, president and CEO of Optigenex, said, “We are excited about the Koyo-sa’s new product and anticipate further expanded growth in sales this year of AC-11 to Japan, not only for AC-11-melon but for other AC-11 nutraceutical products as our message for cellular wellness and healthy aging continues to take hold with our customers.”